Resources

Publications

11/05/2024
- Oncology
Genomic Profiles of Early Progressors vs Exceptional Responders on CDK4/6i in ER+ HER2- Advanced Breast Cancer
SABCS 2024
11/05/2024
- Oncology
Circulating Tumor DNA Predicts Venous Thromboembolism in Minority Patients with Cancers
ASH 2024
11/05/2024
- Oncology
Characterizing Genomic Variants Defining a Plasma Cell Disorder Patient Cohort Using a Broad Next Generation Multi-Gene DNA Sequencing Panel
ASH 2024
11/05/2024
- Oncology
Intrinsic Subtype Distributions Across Inherited Breast Cancer Genes: An Opportunity To Refine Treatment?
ASHG 2024
11/05/2024
- Oncology
BASECAMP-1 Is an Efficient Pre-Screening Study That Identifies Patients With HLA LOH and Provides Mutational, RNA-Seq, and Microbiome Data for Precision Logic-Gated Car T Therapeutic Trials
SITC 2024
11/05/2024
- Oncology
EVEREST-2: A Seamless Phase 1/2 Study of A2B694, a Logic-Gated Tmod Car T-Cell Therapy, in Patients With Mesothelin-Expressing Solid Tumors With Human Leukocyte Antigen-A*02 Loss of Heterozygosity
SITC 2024
11/05/2024
- Oncology
EVEREST-1: Initial Safety Data From a Seamless Phase 1/2 Study of A2B530, a Logic-Gated Tmod Car T-Cell Therapy, in Patients With Solid Tumors Associated With Cea Expression Also Exhibiting HLA-LOH
SITC 2024
11/05/2024
- Oncology
ASPSCR1::TFE3 Type-1 vs. Type-2 Fusions in Alveolar Soft Part Sarcoma (ASPS) Display a Differential Tumor Immune Microenvironment (TIME) Influencing Response to Immune Checkpoint Inhibitors (ICIs)
SITC 2024
11/05/2024
- Oncology
Variable Associations Between Humoral Immune Features And Immune Checkpoint Blockade-Related Outcomes Across Tissues In Metastatic Lung Adenocarcinoma
SITC 2024
11/05/2024
- Oncology
Self-Supervised Representation Learning Enables Genomic Prediction at Single-Organoid Resolution
SITC 2024

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68